News J&J asks FDA for emergency clearance for single-shot COVID-1... Johnson & Johnson’s Janssen unit has filed its single dose COVID-19 vaccine candidate with the FDA, asking for an Emergency Use Authorization (EUA).
R&D J&J and medical device innovation: the pharmaphorum podcast In episode 27 of the pharmaphorum podcast I’m joined by Erin McEachren, who’s EU regional vice president at J&J Surgical Vision.
Views & Analysis The top 5 pharma M&A deals of 2020 2020’s M&A activity hasn’t quite reached the heights of last year’s, where two pharma mega-mergers –
News Janssen combines Darzalex with COVID-19 drug in new multiple... Janssen has submitted a new combination regimen for its blockbuster multiple myeloma drug Darzalex for approval with the FDA and EMA, hoping to give the treatment another edge over emerging comp
News Canada signs deals for J&J, Novavax COVID vaccines The Canadian government has reached agreements in principle with J&J and Novavax to buy their coronavirus vaccine candidates.
Views & Analysis Rebooting the healthcare system post-COVID-19 Janssen’s Iris Zemzoum looks at seven ways the healthcare and pharma sectors need to change in the wake of COVID-19.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends